Huadong Medicine Co. Ltd. (SZSE:000963) said unit and partners plan to invest a combined CNY 300 million ($41.16 million) for 8.6% stake in pharmaceutical firm.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
33.41 CNY | -1.04% | +1.43% | -19.42% |
04-25 | Huadong Medicine Co., Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
04-18 | Huadong Medicine's 2023 Profit Jumps 14% | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-19.42% | 8.09B | |
+20.94% | 72.78B | |
-1.26% | 24.24B | |
+5.13% | 8.59B | |
+8.25% | 8.38B | |
+5.56% | 4.81B | |
+16.83% | 4.32B | |
-1.83% | 4.05B | |
-1.65% | 3.93B | |
+26.97% | 3.79B |
- Stock Market
- Equities
- 000963 Stock
- News Huadong Medicine Co., Ltd
- Huadong Medicine's Unit, Partners to Invest in Pharmaceutical Firm